Mr. Speaker, on June 8, I announced the first phase of consultations on the registration and full disclosure of clinical trial information. That is in keeping with the issue around transparency, accountability and openness in my department. The consultations follow the commitment I made since becoming Minister of Health. Today in Ottawa, the first public workshop will be held and others will follow in Halifax and Vancouver next week.
We are moving in this direction, while taking into account personal privacy and commercial confidentiality.